Solvay SA (SOLB.BR) Investment Analysis:

1. Executive Summary:

This report provides an in-depth investment analysis of Solvay SA (SOLB.BR), the "Essential" chemicals company established following its partial demerger from Syensqo in December 2023. The "new" Solvay is a focused, mature industrial company rooted in the founder's original soda ash business. It operates globally through two primary business segments :

1. Basic Chemicals: This segment is the cash-flow engine, holding a #1 global market share in Soda Ash and a #3 global position in Peroxides. It is defined by its large scale, significant capital requirements, and exposure to global commodity cycles.

2. Performance Chemicals: This is the innovation-focused segment, holding a #1 leadership position in high-value niches, most notably Highly Dispersible Silica (HDS) for the tire industry , alongside its Special Chem and Coatis businesses.

As of November 2025, Solvay presents a stark value-versus-trap dilemma. The company's stock trades at an exceptionally low enterprise value-to-EBITDA multiple of approximately 4.9 times its 2025 guidance and offers a dividend yield in excess of 9%. This valuation reflects a deeply pessimistic market, which is pricing in a severe and structural collapse in the soda ash market—its largest segment—due to a significant increase in Chinese overcapacity. The central investment question explored in this report is whether this structural risk is fully priced into the stock, and if the company's robust cash generation, disciplined cost-cutting, and innovation in Performance Chemicals can provide a floor for the valuation and sustain its dividend.

2. Business Drivers & Strategic Overview:

Core Business Unit Analysis

Solvay's operations are divided into two distinct segments, each with different market characteristics and strategic roles.

Basic Chemicals: This segment is the company's cash-flow engine, generating €2,695 million in 2024 sales and €645 million in underlying EBITDA.

• Soda Ash & Derivatives: Solvay is the global leader in soda ash with an 18% market share. Its primary competitive advantage is a dual-production footprint. It operates low-cost natural trona mines in Green River, Wyoming, USA , and legacy synthetic ammonia-process plants in Europe. This segment serves mature end-markets like glass (flat and container), detergents, and chemicals.

• Peroxides: Solvay is the #3 global player in peroxides , serving markets such as pulp & paper and chemicals. Critically, within this business, Solvay is the #1 leader in high-purity, electronic-grade hydrogen peroxide (eH2O2). This is a high-growth niche essential for the manufacturing of semiconductors, providing a specialized, high-margin driver.

Performance Chemicals: This segment is the company's growth and innovation engine, generating €1,834 million in 2024 sales and €448 million in underlying EBITDA.

• Silica: This is the segment's crown jewel. Solvay is the #1 global leader in Highly Dispersible Silica (HDS). HDS is a high-performance, non-substitutable material used in "green" tires. It is technically essential for reducing rolling resistance, which lowers fuel consumption in combustion vehicles and extends the range of electric vehicles, while also improving safety. This business, with approximately €500 million in sales , benefits from strong pricing power as it directly helps its major customers, such as Michelin and Pirelli, meet their own ambitious sustainability and performance targets.

• Coatis & Special Chem: These units serve various industrial niches, including solvents, phenolics, and rare earths. The Coatis business, however, is facing significant competitive headwinds from Asian producers, mirroring challenges in the soda ash segment.

Strategic Pillars & Growth Initiatives

Management is not passively accepting market pressures. Its strategy is twofold: a robust defensive plan to protect margins and an offensive plan to drive long-term value.

• Defensive Strategy: Aggressive Cost Transformation: Solvay is executing a significant structural cost-saving program. The company delivered €110 million in savings in 2024 and is on track to achieve a cumulative €200 million by the end of 2025. The long-term target is to reach a €350 million annual run-rate by 2028. This initiative is not designed for growth but as a critical defensive measure to offset inflation and margin compression from the soda ash downturn.

• Defensive Strategy: Energy Transition & Decarbonization: This is a key strategic initiative that is both environmental and economic. Solvay is aggressively phasing out coal from its energy-intensive synthetic soda ash plants.

  • The Green River, US, facility completed its coal phase-out in 2024.

  • The Rheinberg, Germany, plant is converting to biomass and is expected to be complete by 2025.

  • The Dombasle, France, plant is converting to waste-to-energy and is also expected to be complete by 2025. This transition structurally reduces CO2 emissions and, just as importantly, insulates the company's European operations from the volatility of fossil fuel costs. The €40 million one-time gain from selling CO2 certificates in Q3 2025 is a direct, tangible financial benefit of this proactive strategy.

• Offensive Strategy: Innovation-led Growth (Circular HDS): This is the company's primary long-term growth driver. Solvay is commercializing a new, patented "circular" HDS made from bio-based sodium silicate derived from rice-husk ash.

  • Production at the Livorno, Italy, plant began in late 2024.

  • A wider rollout is planned, with Asian plants in China and South Korea set for conversion in 2026. This is a sophisticated strategic move. It directly aligns Solvay with the stated 2030 sustainability goals of its largest customers, who are targeting 40% or more circular raw materials in their products. This shifts the sales conversation from "price" to "partnership," creating a deep competitive moat, justifying premium pricing, and securing long-term demand.

Competitive Advantages

Solvay's market position is built on three core advantages:

1. Scale & Market Leadership: Holding #1 positions in both Soda Ash and HDS Silica , and #3 in Peroxides , provides significant economies of scale and high barriers to entry in these capital-intensive industries.

2. Structural Cost Advantage: The company's natural trona mining operations in the US are structurally lower-cost and have a lower emissions profile than synthetic production methods , providing a resilient cash-flow base that can withstand cyclical troughs.

3. Technological Leadership: A 160+ year legacy of process expertise, demonstrated by the new e.Solvay soda ash process and the development of circular HDS , creates a genuine, hard-to-replicate R&D and engineering advantage.

3. Financial Performance & Valuation:

Historical Full-Year 2024 Performance

2024 was the first full year for the new Solvay. The results demonstrate the high underlying profitability and cash-generative nature of the business before the structural soda ash downturn fully materialized in 2025.

2025 Performance & Guidance: Deconstructing the "Real" EBITDA

The financial story in 2025 has been one of severe market deterioration, particularly in Soda Ash and the Coatis business. In response, management revised its 2025 outlook downward. As of November 2025, Solvay guides for a full-year Underlying EBITDA between €880 million and €930 million.

However, this headline guidance is misleading. A deeper analysis of the quarterly results reveals that the guidance is inflated by significant non-operational, one-off gains:

• Q2 2025: A €20 million gain was recognized from a terminated customer contract.

• Q3 2025: A €40 million gain was recognized from the strategic sale of CO2 emissions certificates.

To understand the true health of the core business, these €60 million in one-off gains must be excluded.

This analysis clarifies that the "real" underlying business is experiencing a ~20% collapse in operating profit, which has been partially masked by these one-off items. This confirms the company is in a deep cyclical and structural trough.

Current Valuation (as of November 6, 2025)

The market valuation reflects this severe operational decline.

An EV/EBITDA multiple of ~5.0x is in deep-value, if not distressed, territory for a leading chemical company. This multiple implies the market believes earnings have no path to recovery and may fall further. The >9% dividend yield is a major distress signal, suggesting the market is pricing in a high probability of a dividend cut.

Capital Allocation Policy: The Dividend Linchpin

The company's stated capital allocation policy is disciplined and shareholder-friendly :

1. Invest: Prioritize "essential capex" of €250-300 million per year, including energy transition projects. FY 2025 capex is capped at €300 million.

2. Reward: Pay "stable to increasing dividends," using a €260 million total annual payout as the floor.

3. Grow: Use excess cash for growth capex (like Circular HDS) or additional shareholder returns.

The central tension of the investment thesis lies in the dividend.

• A €2.43 dividend per share on 105.88 million shares equates to a €257.3 million annual cash cost.

• This aligns perfectly with the stated €260 million dividend floor.

• Management's FY 2025 Free Cash Flow (FCF) guidance is ~€300 million.

This implies a Free Cash Flow Payout Ratio of ~86% (€257.3M / €300M). This is a high-wire act. Management is signaling its conviction that 2025 represents the trough of the cycle and that they will defend the dividend, but it leaves virtually no room for error. Share buybacks, like those seen in 2024 , are off the table until FCF generation improves dramatically.

4. Risk Assessment & Macroeconomic Considerations:

Primary Risk: Structural Collapse in Soda Ash (The Bear Thesis)

This is the single most significant risk facing the company and the primary driver of its low valuation. The weakness in the soda ash market is not a normal cyclical downturn; it is a structural shift.

• Cause: A massive, ongoing build-out of new, low-cost soda ash capacity in China.

• Effect: Berenberg analysts noted in an October 2025 report that Chinese capacity is growing at a compound annual growth rate (CAGR) of 6%, while global demand is growing at only 2-3%. This has created a significant glut, flooding the Southeast Asian market—a key export destination for Solvay—and crushing prices.

• Impact: This trend directly attacks Solvay's largest and most profitable segment. The ~20% collapse in "real" 2025 EBITDA is a direct result. Analysts warn that this pain will continue, with 2026/2027 consensus estimates still appearing too high. This structural headwind makes Solvay's 2028 target of "mid-single-digit" EBITDA growth seem highly unrealistic.

Portfolio & Cyclical Risks

• Coatis Segment Weakness: The Coatis business (phenolics, solvents) is experiencing a sharp downturn, impacted by "strong Asian competition and U.S. tariffs". This mirrors the soda ash problem, suggesting a broader competitive issue with low-cost Asian exports.

• End-Market Exposure: Solvay remains exposed to cyclical end-markets, including construction and automotive. A "soft demand environment" in these sectors provides a weak macroeconomic overlay to the company's structural risks.

Environmental & Legal Liabilities (The PFAS "Head-Fake")

The chemical industry faces an existential crisis from "forever chemical" (PFAS) litigation, with settlements from other companies reaching the tens of billions. "Old" Solvay was a primary target in these investigations.

However, a deep analysis of the post-demerger corporate structure reveals that the "new" Solvay (SOLB) has offloaded the primary PFAS risk.

• The December 2023 demerger spun off the "Specialty Polymers" division into the new company, Syensqo.

• The major US lawsuit, relating to the West Deptford, NJ, site, was for fluorinated polymers produced at that site.

• The resulting ~$393 million settlement is tied to "Solvay Specialty Polymers USA, LLC," which is now a subsidiary of Syensqo.

The "new" Solvay's retained environmental liabilities are for other sites (e.g., remediation at Salindres, France ) and are far more quantifiable. The 2024 Annual Integrated Report lists environmental contingent liabilities at €210 million. This is a manageable provision, not a balance-sheet-destroying threat. The market is likely mis-pricing this risk, conflating SOLB with its former (and far riskier) self.

Macroeconomic Considerations

• Energy Costs: As a heavy industrial producer, Solvay's margins are highly sensitive to natural gas and other energy prices, particularly at its European synthetic plants. The company's energy transition strategy is a critical long-term hedge against this volatility.

• Foreign Exchange: The company reports in Euros but has significant US (trona) and Asian operations. A strong US dollar is a net positive. Recent company guidance is based on a EUR/USD exchange rate of 1.05.

5. 5-Year Scenario Analysis (FY2026 - FY2030):

This analysis projects the 5-year total return based on three scenarios. The starting point is our "True" Operational EBITDA estimate for FY2025 of €845 million. The core dividend is assumed to be held at €2.43/share (€257.3M total) in all but the most severe case, as per management's "stable" policy. All projections are from this 2025 base.

Key Financial Inputs & Assumptions (Provenance):

• Current Share Price (Nov 2025): €26.50

• Shares Outstanding: 105.88M

• Base FY2025 "True" EBITDA: €845M (Section 3 Analysis)

• Base FY2025 Net Debt: €1.7B

• Base Annual Capex: €300M

• Base Annual Dividend Payout: €257.3M (Section 3 Analysis)

• Base FCF (to shareholders): ~€300M (Aligns with guidance )

• Net Debt evolves based on FCF after dividend payments.

Base Case: "Muddle Through"

Subjective Probability: 50%

• Key Fundamentals: This scenario assumes the soda ash market is structurally impaired but not in freefall. Chinese competition puts a permanent cap on Basic Chemical margins, leading to zero growth. All modest group growth is driven by the Performance Chemicals segment, led by Circular HDS. Management achieves its cost-cutting targets , which offset inflation and margin pressure. The dividend is maintained and covered by FCF.

• Financial Drivers:

  • Revenue Growth (CAGR): 1.5% (Basic Chemicals 0%, Performance Chemicals 3.5%).

  • EBITDA: Begins at €845M and grows by an average of 2.0% CAGR (cost cuts + HDS growth offsetting soda ash weakness).

  • Terminal EV/EBITDA Multiple: 5.5x. This is a slight recovery from the current trough (5.3x), reflecting a stabilized, low-growth, high-yield utility-like business.

• Projected 5-Year Financials (Base Case):

• Valuation & Share Price Trajectory (Base Case):

Low Case: "The Soda Ash Trap"

Subjective Probability: 30%

• Key Fundamentals: The Berenberg bear case is fully realized and permanent. Chinese overcapacity (6% CAGR vs 2-3% demand) leads to a relentless price war. Solvay's "essential" soda ash business becomes a "commodity" in the worst sense. Margin pressure in Basic Chemicals is severe. The Coatis business also folds under Asian competition. Cost cuts are achieved but are insufficient to offset the margin collapse. Management is forced to cut the dividend to protect the balance sheet.

• Financial Drivers:

  • Revenue Growth (CAGR): -1.0% (Basic Chemicals -2.5%, Performance Chemicals +1.0%).

  • EBITDA: Begins at €845M and declines by -2.0% CAGR, ending at €765M.

  • Dividend: The dividend is cut in 2027 from €2.43 to €1.22 (a 50% cut) to preserve cash.

  • Terminal EV/EBITDA Multiple: 4.5x. The market treats the stock as a distressed commodity producer with no growth and declining margins.

• Projected 5-Year Financials (Low Case):

• Valuation & Share Price Trajectory (Low Case):

High Case: "Sustainability Re-rating"

Subjective Probability: 20%

• Key Fundamentals: The soda ash market stabilizes as Chinese capacity proves less efficient or demand from "green" applications (like battery recycling ) accelerates faster than expected. The real driver is the Performance Chemicals segment. The "Circular HDS" is a massive success. Tire makers, locked in a "green arms race," grant Solvay premium pricing and long-term contracts. This segment grows at high-single-digits, changing the narrative of the company from a "Basic Chemical" producer to a "Specialty Enabler." Cost cuts and energy transition savings drop straight to the bottom line. FCF generation soars, leading to dividend increases and buybacks.

• Financial Drivers:

  • Revenue Growth (CAGR): 3.5% (Basic Chemicals 1.5%, Performance Chemicals 6.0%).

  • EBITDA: Begins at €845M and grows by an average of 5.0% CAGR, ending at €1,079M (exceeding 2024 levels).

  • Dividend: The dividend is raised by 5% per year starting in 2027.

  • Terminal EV/EBITDA Multiple: 6.5x. The market re-rates the stock as its business mix shifts to higher-growth, higher-margin specialty products.

• Projected 5-Year Financials (High Case):

• Valuation & Share Price Trajectory (High Case):

Scenario Summary & Probability-Weighted Outcome:

• Probability-Weighted Price Target (2030):

  • (20% €55.17) + (50% €35.86) + (30% €20.49) = €11.03 + €17.93 + €6.15 = €35.11

• Probability-Weighted Cumulative Dividend:

  • (20% €13.52) + (50% €12.15) + (30% * €8.59) = €2.70 + €6.08 + €2.58 = €11.36

• Probability-Weighted 5-Year Total Return: €20.00 (vs. €26.50 price)

• Probability-Weighted Annualized Return (CAGR): +11.9%

DEEPLY UNDERVALUED

6. Qualitative Scorecard:

• Management Alignment: 3/10

  • Narrative: Alignment appears weak. While CEO Philippe Kehren did purchase shares in July 2025, the amount was ~€30,000. This is a token gesture, not a high-conviction investment. The 2024 CEO compensation of €2.3 million is reasonable , and shareholders approved a new remuneration policy in May 2025. However, there is no evidence of significant insider ownership that would align management's financial fate with that of minority shareholders. The defense of the dividend is the strongest alignment signal.

• Revenue Quality: 4/10

  • Narrative: This is a mixed and currently poor-quality stream. The Basic Chemicals segment (Soda Ash), the largest contributor , is a global commodity business facing margin-crushing oversupply. This is low-quality revenue. The Performance Chemicals (HDS Silica) segment has much higher-quality, sticky, innovation-led revenue , but it is the smaller part of the portfolio. The €60 million in one-off gains in 2025 also point to low-quality "earnings."

• Market Position: 8/10

  • Narrative: Solvay's market positions are excellent. It is #1 globally in Soda Ash (18% share) , #1 in HDS Silica , and #3 in Peroxides. Its competitive moat is built on 160+ years of process technology, global scale, and (in the US) a structural cost advantage. The position is strong; the market is the problem.

• Growth Outlook: 2/10

  • Narrative: The near-term (2025-2027) growth outlook is poor. The company is in a deep "earnings recession," with "real" operational EBITDA down ~20% (Section 3 Analysis). The 2028 "mid-single-digit" growth target appears highly optimistic. The only plausible growth driver is the Circular HDS business , which is not yet large enough to offset the structural decline in the larger soda ash segment.

• Financial Health: 7/10

  • Narrative: Financial health is solid. Leverage (Net Debt/EBITDA) is low, rising from 1.5x in 2024 to an estimated 1.8x in 2025 due to the earnings drop. This is a very manageable level of debt and provides the company with the flexibility to navigate the downturn without a balance sheet crisis. The FCF coverage of the dividend is dangerously thin , which is a weakness, but the low absolute debt is a major strength.

• Business Viability: 9/10

  • Narrative: The long-term viability of the business is not in question. It produces "essential" chemicals with high barriers to entry. Soda ash is fundamental to glass, and HDS silica is fundamental to modern tires. The company has a 160+ year history , significant assets, and leadership in its fields. It will survive this downturn.

• Capital Allocation: 6/10

  • Narrative: Management has a clear, disciplined 3-step policy : 1. Capex, 2. Dividend, 3. Growth/Buybacks. This is a good framework. However, the decision to defend the dividend at an ~86% FCF payout ratio is aggressive. It signals confidence but leaves zero room for error. A more conservative board might have rebased the dividend to build a buffer.

• Analyst Sentiment: 2/10

  • Narrative: Sentiment is poor and deteriorating. The stock is rated "Neutral" by consensus. The most recent high-profile report from Berenberg (October 2025) was a downgrade to "Sell" , citing the structural Chinese overcapacity. Consensus estimates for 2026/2027 are 10% above Berenberg's, suggesting more downgrades are likely.

• Profitability: 5/10

  • Narrative: Solvay has historically been a high-profitability company, with a 2024 EBITDA margin of 22.5%. However, this profitability is collapsing in 2025. The "real" operational EBITDA margin is contracting significantly as the company is forced to absorb commodity price deflation.

• Track Record: 6/10

  • Narrative: As a "new" company post-demerger, the track record is short. What we have seen (FY2024 - FY2025) is a mixed bag. Management delivered on 2024 promises and is executing on cost-cuts. However, they were slow to admit the severity of the soda ash downturn. Executing the demerger itself was a significant positive event.

• Overall Blended Score: 5.2/10

PRICED FOR PRESSURE

7. Conclusion & Investment Thesis:

• Summary: Solvay SA is a market-leading, highly cash-generative "Essential" chemical business. It possesses strong #1 market positions, a solid balance sheet with low leverage, and a clear capital allocation policy. However, its largest segment, Soda Ash, is in the midst of a structural crisis due to Chinese overcapacity, which has caused a ~20% collapse in "real" operational EBITDA in 2025.

• Investment Thesis: The current valuation (a ~5.0x EV/EBITDA multiple and a >9% dividend yield) suggests the market has fully priced in the "Low Case" scenario—that Solvay is a declining commodity producer in a permanently impaired market.

• The central thesis is that this pessimism is overdone.

  1. Risk Mis-pricing: The market is likely still applying a "PFAS discount" that is no longer warranted. The most significant liabilities were spun off to Syensqo , and the "new" Solvay's retained environmental liabilities of €210 million are manageable.

  2. Dividend Anchor: Management is signaling its conviction by defending the €2.43 dividend, which it can just cover with 2025's guided FCF. This provides a powerful cash-flow anchor for the valuation.

  3. Hidden Growth: The bull case, driven by the high-margin, high-growth Circular HDS business , is completely ignored by the market. This business has the potential to change the company's narrative and unlock a re-rating.

• The investment case hinges on 2025 being the trough. The 5-year scenario analysis suggests a +11.9% probability-weighted annualized return, driven by the Base Case. The risk-reward is asymmetric to the upside, as the stock is already valued for a crisis.

YIELD OR TRAP?

8. Technical Analysis, Price Action & Short-Term Outlook:

The stock is in a clear and severe downtrend, trading well below its 200-day moving average of approximately €29.71 and its 50-day moving average of approximately €27.28. The Relative Strength Index (RSI) is low at ~34-36 , approaching oversold territory but not yet signaling capitulation. Recent price action has been negative, driven by the October 2025 Berenberg downgrade to "Sell" , which confirmed the market's worst fears on soda ash.

BEARISH TREND